首页> 外文期刊>Journal of the air & waste management association >Ambient fine particulate matter in China: Its negative impacts and possible countermeasures
【24h】

Ambient fine particulate matter in China: Its negative impacts and possible countermeasures

机译:中国环境细颗粒物的负面影响及可能的对策

获取原文
获取原文并翻译 | 示例
       

摘要

In recent decades, China has experienced rapid economic development accompanied by increasing concentrations of ambient PM_2.5, particulate matter of less than 2.5 urn in diameter. PM_2.5 is now believed to be a carcinogen, causing higher lung cancer risks and generating losses to the economy and society. This meta-analysis evaluates the losses generated by ambient PM_2.5 in Suzhou from 2014 to 2016 and predicts losses at different concentrations. Estimations of total losses in Beijing, Shanghai, Hangzhou, Guangzhou, Dalian, and Xiamen are also presented, with a total national loss in 2015. The authors then demonstrate that lowering ambient PM_2.5 concentrations would be a realistic way for China to reduce the evaluated social losses in the short term. Possible legal measures are listed for lowering ambient PM_2.5 concentrations. Implications: The present findings quantify the economic effects of ambient PM_2.5 due to the increased incidence rate and mortality rate of lung cancer. Lowering ambient PM_2.5 concentrations would be the most realistic way for China to reduce tghe evaluated social losses in the short term. Possible legal measures for lowering ambient PM25 concentrations to reduce the total losses are identified.
机译:近几十年来,中国经历了快速的经济发展,伴随着周围PM_2.5(直径小于2.5微米的颗粒物)浓度的增加。现在认为PM_2.5是致癌物,会引起更高的肺癌风险并给经济和社会造成损失。该荟萃分析评估了2014年至2016年苏州环境PM_2.5产生的损失,并预测了不同浓度下的损失。还介绍了北京,上海,杭州,广州,大连和厦门的总损失估算,2015年全国总损失。作者随后证明,降低环境PM_2.5浓度将是中国降低大气中PM_2.5浓度的现实方法。在短期内评估了社会损失。列出了降低环境PM_2.5浓度的可能法律措施。启示:由于肺癌的发病率和死亡率的增加,本研究结果量化了环境PM_2.5的经济影响。降低环境中的PM_2.5浓度将是中国短期内减少评估的社会损失的最现实方法。确定了降低环境PM25浓度以减少总损失的可能法律措施。

著录项

  • 来源
  • 作者单位

    Suzhou High School of Jiangsu Province, Suzhou, People's Republic of China;

    University of Toronto, Toronto, Ontario, Canada;

    Department of Medical Affairs, Suzhou Hospital of Traditional Medicine, Suzhou, People's Republic of China;

    Jiangsu Institute of Hematology, Departments of Urology and Hematology, the First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:29:29

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号